Trial Profile
Faslodex International Observational Non-Interventional Study in Advanced Breast Cancer.
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 06 Dec 2011
Price :
$35
*
At a glance
- Drugs Fulvestrant (Primary)
- Indications Advanced breast cancer
- Focus Therapeutic Use
- Acronyms FIONA
- Sponsors AstraZeneca
- 29 Nov 2011 Actual start date (Apr 2009) added as reported by ClinicalTrials.gov.
- 29 Nov 2011 Actual end date (Dec 2010) added as reported by ClinicalTrials.gov.
- 29 Nov 2011 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.